An Atlas of the Human Kinome Reveals the Mutational Landscape Underlying Dysregulated Phosphorylation Cascades in Cancer

Kinase inhibitors are used widely to treat various cancers, but adaptive reprogramming of kinase cascades and activation of feedback loop mechanisms often contribute to therapeutic resistance. Determining comprehensive, accurate maps of kinase circuits may therefore help elucidate mechanisms of resp...

Full description

Saved in:
Bibliographic Details
Published inCancer research (Chicago, Ill.) Vol. 76; no. 7; pp. 1733 - 1745
Main Authors Olow, Aleksandra, Chen, Zhongzhong, Niedner, R Hannes, Wolf, Denise M, Yau, Christina, Pankov, Aleksandr, Lee, Evelyn Pei Rong, Brown-Swigart, Lamorna, van 't Veer, Laura J, Coppé, Jean-Philippe
Format Journal Article
LanguageEnglish
Published United States 01.04.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Kinase inhibitors are used widely to treat various cancers, but adaptive reprogramming of kinase cascades and activation of feedback loop mechanisms often contribute to therapeutic resistance. Determining comprehensive, accurate maps of kinase circuits may therefore help elucidate mechanisms of response and resistance to kinase inhibitor therapies. In this study, we identified and validated phosphorylatable target sites across human cell and tissue types to generate PhosphoAtlas, a map of 1,733 functionally interconnected proteins comprising the human phospho-reactome. A systematic curation approach was used to distill protein phosphorylation data cross-referenced from 38 public resources. We demonstrated how a catalog of 2,617 stringently verified heptameric peptide regions at the catalytic interface of kinases and substrates could expose mutations that recurrently perturb specific phospho-hubs. In silico mapping of 2,896 nonsynonymous tumor variants identified from thousands of tumor tissues also revealed that normal and aberrant catalytic interactions co-occur frequently, showing how tumors systematically hijack, as well as spare, particular subnetworks. Overall, our work provides an important new resource for interrogating the human tumor kinome to strategically identify therapeutically actionable kinase networks that drive tumorigenesis. Cancer Res; 76(7); 1733-45. ©2016 AACR.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Co-first authors
ISSN:0008-5472
1538-7445
DOI:10.1158/0008-5472.CAN-15-2325-T